Instrument Inactif

Communiqués Peptonic Medical AB Nasdaq Stockholm

Actions

Recherche biotechnologique et médicale

Cours en clôture Nasdaq Stockholm
- ^SEK	-

11:59	Peptonic Medical enregistre une commande américaine pour ses produits de santé intime féminine	MT
11:05	Peptonic Medical reçoit une nouvelle commande de son partenaire américain	FW

Communiqués

11:01	Peptonic Medical receives additional order from US partner in women's intimate health	AQ
19/08	Peptonic Medical AB (publ) - Publishes financial report for the second quarter 2026	AQ
11/08	Peptonic Medical AB announces change in the board	AQ
24/06	Bulletin from the annual general meeting in Peptonic Medical AB (publ)	AQ
24/06	Peptonic Medical AB Presents Nominations for Board Members Ahead of the Annual General Meeting on June 24, 2026	AQ
15/06	Peptonic receives approximately SEK 7.5 million through warrants of series TO6	AQ
10/06	Peptonic Medical AB publishes its Annual Report for the 2025 financial year	AQ
10/06	Peptonic Medical completes first delivery to strategic US partner - a key milestone in the company's international expansion	AQ
09/06	The last day of trading with the warrants of series TO6 in Peptonic Medical AB is today, June 9, 2026	AQ
08/06	Peptonic Medical AB - Major shareholder exercises warrants to subscribe for shares	AQ
04/06	Peptonic Medical AB announces a new date for the publication of its annual report	AQ
03/06	Peptonic Medical launches a new product segment in health and beauty - strengthening growth opportunities through a broader offering and a new brand	AQ
01/06	Peptonic Medical: The subscription price for warrants of series TO6 in Peptonic has been determined to SEK 0.0011 and the exercise period begins today	PU
01/06	The subscription price for warrants of series TO6 in Peptonic has been determined to SEK 0.0011 and the exercise period begins today	AQ
29/05	Peptonic Medical nears first delivery to strategic partner in the US - a key milestone in its international expansion	AQ
27/05	Peptonic Medical AB (publ) - Publishes financial report for the first quarter 2026	AQ
26/05	NOTICE OF THE ANNUAL GENERAL MEETING OF PEPTONIC MEDICAL AB	AQ
22/05	Peptonic Medical Launches VagiVital Moisturizing Intimate Cream, Further Expanding Its Portfolio of Moisturizing Intimate Care Products	AQ
20/05	Peptonic Medical is expanding its portfolio in the intimate self-care category and launching VagiVital Intimate V Wipes	AQ
19/05	Peptonic postpones the Annual General Meeting and publication of the annual report	AQ
28/04	Peptonic provides an update on Vernivia	AQ
27/02	Peptonic Medical () : Publishes Year-end report for 2025	PU
27/02	Peptonic Medical AB (publ) - Publishes Year-end report for 2025	AQ
26/02	Peptonic Medical AB - Board of Directors appoints Daniel Rudeklint as interim CEO	AQ
25/02	Peptonic Medical AB announces termination of liquidity provider agreement	AQ